Infliximab biosimilar-to-biosimilar switching in 1,605 patients with inflammatory rheumatic diseases: Clinical outcomes in real-world patients from the DANBIO registry
- Hafsah Nabi (Speaker)
- Merete Lund Hetland (Co-author)
- Hendricks, O. (Co-author)
- Dorte Vendelbo Jensen (Co-author)
- Jens Kristian Pedersen (Co-author)
- Just, S. A. (Co-author)
- K. Danebod (Co-author)
- Munk, H. L. (Co-author)
- S. Kristensen (Co-author)
- Natalia Manilo (Co-author)
- Ada Colic (Co-author)
- Asta Linauskas (Co-author)
- P H Thygesen (Co-author)
- L. B. Christensen (Co-author)
- Maren Høgberget Kalisz (Co-author)
- N. Lomborg (Co-author)
- Jolanta Grydehøj (Co-author)
- Johnny Lillelund Raun (Co-author)
- R Ahmed (Co-author)
- Frank Mehnert (Co-author)
- Niels Steen Krogh (Co-author)
- Bente Glintborg (Co-author)
Activity: Talks and presentations › Conference presentations